Related references
Note: Only part of the references are listed.Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo- controlled, phase 3 trial (BE OPTIMAL)
Iain B. McInnes et al.
LANCET (2023)
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)
Joseph F. Merola et al.
LANCET (2023)
Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE
Philip J. Mease et al.
RHEUMATOLOGY (2023)
AB0011 CYTOMETRIC ANALYSIS OF ACTIVATED ENTHESEAL TISSUE RESIDENT T-CELLS REVEALS IL-17F AS THE DOMINANT IL-17 ISOFORM EXPRESSED BY INNATE AND ADAPTIVE LYMPHOCYTES
N. Mcdermott et al.
ANNALS OF THE RHEUMATIC DISEASES (2023)
The Role of Neutrophils in Spondyloarthritis: A Journey across the Spectrum of Disease Manifestations
Lavinia Agra Coletto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Characterization of Blood Mucosal-Associated Invariant T Cells in Patients With Axial Spondyloarthritis and of Resident Mucosal-Associated Invariant T Cells From the Axial Entheses of Non-Axial Spondyloarthritis Control Patients
Nicolas Rosine et al.
ARTHRITIS & RHEUMATOLOGY (2022)
Neutrophil breaching of the blood vessel pericyte layer during diapedesis requires mast cell-derived IL-17A
Regis Joulia et al.
NATURE COMMUNICATIONS (2022)
Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study
Laura C. Coates et al.
ARTHRITIS & RHEUMATOLOGY (2022)
Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis
April Armstrong et al.
DERMATOLOGY AND THERAPY (2022)
Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge
Angelo Ruggiero et al.
PSORIASIS-TARGETS AND THERAPY (2022)
Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study
Atul Deodhar et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Tissue-Resident Memory CD8+T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis
Emmerik F. Leijten et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Innate Cells: The Alternative Source of IL-17 in Axial and Peripheral Spondyloarthritis?
Nicolas Rosine et al.
FRONTIERS IN IMMUNOLOGY (2021)
Novel immune cell phenotypes in spondyloarthritis pathogenesis
Daniele Mauro et al.
SEMINARS IN IMMUNOPATHOLOGY (2021)
The Role of Natural Killer Cells in Autoimmune Diseases
Umut Can Kucuksezer et al.
FRONTIERS IN IMMUNOLOGY (2021)
MAIT cells, guardians of skin and mucosa?
Isabelle Nel et al.
MUCOSAL IMMUNOLOGY (2021)
Recent Updates in the Immunopathology of Type 3 Immunity-Mediated Enthesitis
Akihiro Nakamura et al.
CURRENT RHEUMATOLOGY REPORTS (2021)
Interleukin-17 family members in health and disease
Soo-Hyun Chung et al.
INTERNATIONAL IMMUNOLOGY (2021)
Dual inhibition of IL-17A and IL-17F in psoriatic disease
Helena Iznardo et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2021)
Polyfunctional, Proinflammatory, Tissue-Resident Memory Phenotype and Function of Synovial Interleukin-17A+CD8+T Cells in Psoriatic Arthritis
Kathryn J. A. Steel et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Functional significance of MAIT cells in psoriatic arthritis
Smriti K. Raychaudhuri et al.
CYTOKINE (2020)
Presence, function, and regulation of IL-17F-expressing human CD4+ T cells
Lachrissa A. Burns et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
The Interleukin (IL) 17R/IL-22R Signaling Axis Is Dispensable for Vulvovaginal Candidiasis Regardless of Estrogen Status
Brian M. Peters et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Interleukin 17A and IL-17F Expression and Functional Responses in Rheumatoid Arthritis and Peripheral Spondyloarthritis
Sijia Chen et al.
JOURNAL OF RHEUMATOLOGY (2020)
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
Atul Deodhar et al.
LANCET (2020)
Interleukin-17 producing mucosal associated invariant T cells - emerging players in chronic inflammatory diseases?
Marta M. Pisarska et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
The Cytokine IL-17A Limits Th17 Pathogenicity via a Negative Feedback Loop Driven by Autocrine Induction of IL-24
Wai Po Chong et al.
IMMUNITY (2020)
Interleukin (IL)-12 and IL-18 Synergize to Promote MAIT Cell IL-17A and IL-17F Production Independently of IL-23 Signaling
Suzanne Cole et al.
FRONTIERS IN IMMUNOLOGY (2020)
The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
Dennis G. McGonagle et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Increased frequency of activated CD8+ T cell effectors in patients with psoriatic arthritis
Marco Diani et al.
SCIENTIFIC REPORTS (2019)
Evidence that tissue resident human enthesis γδT-cells can produce IL-17A independently of IL-23R transcript expression
Richard James Cuthbert et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Histologic evidence that mast cells contribute to local tissue inflammation in peripheral spondyloarthritis by regulating interleukin-17A content
Sijia Chen et al.
RHEUMATOLOGY (2019)
RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients
Koen Venken et al.
NATURE COMMUNICATIONS (2019)
Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications
Leticia Monin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Cutting Edge: Homeostasis of Innate Lymphoid Cells Is Imbalanced in Psoriatic Arthritis
Alina Soare et al.
JOURNAL OF IMMUNOLOGY (2018)
Suppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing Treg cells through modification of the intestinal microbiota
Ce Tang et al.
NATURE IMMUNOLOGY (2018)
IL-17 in the immunopathogenesis of spondyloarthritis
Leonie S. Taams et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Increased IL-22-and IL-17A-Producing Mucosal-Associated Invariant T Cells in the Peripheral Blood of Patients With Ankylosing Spondylitis
Eric Toussirot et al.
FRONTIERS IN IMMUNOLOGY (2018)
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
Dominique Baeten et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
Andrew Blauvelt et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2018)
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological diseasemodifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
Desiree van der Heijde et al.
LANCET (2018)
Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation
Sophie Glatt et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties
Arnaud Goepfert et al.
SCIENTIFIC REPORTS (2017)
Group 3 Innate Lymphoid Cells in Human Enthesis
Richard J. Cuthbert et al.
ARTHRITIS & RHEUMATOLOGY (2017)
IL-17 and IFN-γ producing NK and γδ-T cells are preferentially expanded in synovial fluid of patients with reactive arthritis and undifferentiated spondyloarthritis
Abhra Chandra Chowdhury et al.
CLINICAL IMMUNOLOGY (2017)
IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis
Eric Gracey et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients
G. Guggino et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
IL-17+CD8+T cells: Differentiation, phenotype and role in inflammatory disease
Ushani Srenathan et al.
IMMUNOLOGY LETTERS (2016)
Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis
Christoph S. N. Klose et al.
NATURE IMMUNOLOGY (2016)
Interleukin-23-Dependent/T Cells Produce Interleukin-17 and Accumulate in the Enthesis, Aortic Valve, and Ciliary Body in Mice
Annika Reinhardt et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis
Francesco Ciccia et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Dominique Baeten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1
Adrian Cortes et al.
NATURE COMMUNICATIONS (2015)
Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis
John Bowes et al.
NATURE COMMUNICATIONS (2015)
Enrichment of Activated Group 3 Innate Lymphoid Cells in Psoriatic Arthritis Synovial Fluid
Emmerik F. A. Leijten et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Secretion of interleukin-17 by CD8+T cells expressing CD146 (MCAM)
Pradeep K. Dagur et al.
CLINICAL IMMUNOLOGY (2014)
Cellular sources of IL-17 in psoriasis: a paradigm shift?
Romy R. M. C. Keijsers et al.
EXPERIMENTAL DERMATOLOGY (2014)
Interleukin-17+CD8+T Cells Are Enriched in the Joints of Patients With Psoriatic Arthritis and Correlate With Disease Activity and Joint Damage Progression
Bina Menon et al.
ARTHRITIS & RHEUMATOLOGY (2014)
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Sarah L. Gaffen et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Th17 and Th22 cells in psoriatic arthritis and psoriasis
Helen Benham et al.
ARTHRITIS RESEARCH & THERAPY (2013)
HLA Associations Reveal Genetic Heterogeneity in Psoriatic Arthritis and in the Psoriasis Phenotype
Robert Winchester et al.
ARTHRITIS AND RHEUMATISM (2012)
Interleukin 7 (IL-7) selectively promotes mouse and human IL-17-producing γδ cells
Marie-Laure Michel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Regulation of epithelial immunity by IL-17 family cytokines
Rajita Pappu et al.
TRENDS IN IMMUNOLOGY (2012)
Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells
Mathilde Dusseaux et al.
BLOOD (2011)
CCR6 and NK1.1 distinguish between IL-17A and IFN-γ-producing γδ effector T cells
Jan D. Haas et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Interleukin-17-Producing γδ T Cells Selectively Expand in Response to Pathogen Products and Environmental Signals
Bruno Martin et al.
IMMUNITY (2009)
The STIR-domain superfamily in signal transduction, development and immunity
M Novatchkova et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding
SG Hymowitz et al.
EMBO JOURNAL (2001)
Share Paper
